http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I250319-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_669c01133740c5233f2c8738904ea3af
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-133543
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02F1-1335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B5-3083
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02B5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G77-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-1335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-13
filingDate 2002-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e17d89357e972cdb4183c79464896150
publicationDate 2006-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-I250319-B
titleOfInvention Method for making optical device with circularly-polarized light control
abstract A liquid crystal layer 3 (figure 1a) exhibiting a cholesteric order is formed on an alignment film 2 on a substrate 1 by attaching active radiating cured liquid crystal composition and adjusting the alignment status of the liquid crystal composition by heating. Next, The liquid crystal layer 3 is irradiated with active radiation 4 of predetermined irradiation intensity transmitted through a photomask 10 (figure 1b), and the liquid crystal layer 3 is brought into contact with a solvent 5 (figure 1c), thereby removing the part 3b of the liquid crystal layer 3 not irradiated by active radiation 4 and retaining the part 3a irradiated by active radiation 4 so as to form a semi-cured cholesteric layer 3' having a predetermined pattern (figure 1d). Then, the semi-cured cholesteric layer 3' is irradiated with active radiation 6 to cure the semi-cured cholesteric layer 3' with a curing rate gradation from the base 9 side toward the surface opposite to the base 9, so that the selected reflection wavelength band of the semi-cured cholesteric layer 3' is widened (figure 1e). Lastly, by irradiating the semi-cured cholesteric layer 3' with active radiation 8, the semi-cured cholesteric layer 3' is cured while maintaining the cholesteric order in the widened band status, thereby forming a cured cholesteric layer 3"" (figure 1f).
priorityDate 2001-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID110912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7043
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13019
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3015276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411314150
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415753259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419645377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410498315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3018799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9795026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414862845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416218223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407604914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410564737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416220769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3018647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415814257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407327152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415863310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410569088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416220901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448012403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414887309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157476125
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12242676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415899160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415789334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507379

Total number of triples: 72.